Invesco Ltd. Quotient LTD Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

Shares

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 15, 2022	SELL	$0.24 - $1.2 $6,344 - $31,722	-26,435 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.94 - $2.38 $613 - $1,554	-653 Reduced 2.41%	26,435 $32,000
Q4 2021 Feb 14, 2022	SELL	$1.89 - $3.12 $14,757 - $24,360	-7,808 Reduced 22.38%	27,088 $70,000
Q3 2021 Nov 15, 2021	BUY	$2.34 - $3.77 $16,115 - $25,963	6,887 Added 24.59%	34,896 $81,000
Q2 2021 Aug 17, 2021	BUY	$3.48 - $4.45 $30,244 - $38,674	8,691 Added 44.99%	28,009 $102,000
Q1 2021 May 17, 2021	BUY	$3.57 - $6.2 $12,202 - $21,191	3,418 Added 21.5%	19,318 $71,000
Q4 2020 Feb 16, 2021	BUY	$4.4 - $7.32 $69,960 - $116,388	15,900 New	15,900 $83,000
Q2 2019 Aug 14, 2019	SELL	$7.91 - $10.25 $854,983 - $1.11 Million	-108,089 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$6.0 - $11.07 $197,646 - $364,656	-32,941 Reduced 23.36%	108,089 $974,000
Q4 2018 Feb 14, 2019	BUY	$5.81 - $7.89 $819,384 - $1.11 Million	141,030 New	141,030 $863,000

Others Institutions Holding QTNT

# of Institutions

1

Shares Held

1.71K

Call Options Held

0

Put Options Held

0

Brewin Dolphin LTD London, X0

1.71K
Shares

$68
0.0% of portfolio

About Quotient Ltd

Ticker QTNT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Description
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological di...

More about QTNT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.